Abstract
Human immunodeficiency virus-1 (HIV-1) gene expression is controlled by cellular transcription factors and by virally encoded trans-activation proteins of the HIV-1 tat and art/trs genes, which are essential for viral replication1,9–11. Tat trans-activates HIV-1 gene expression by interacting with the trans-acting response element (TAR) located within the HIV-1 long terminal repeat (LTR) (ref. 2). In transient expression assays, tat mediates its effects largely by increasing the steady-state levels of messenger RNA species that contain the TAR sequence at or near their 5′ ends2–4, suggesting a function for tat either in transcription or in subsequent RNA processing. The tat gene could also facilitate translation of mRNA containing the TAR sequence5–8. To determine the mechanism of trans-activation by tat, we analysed the structure and rate of synthesis of RNA species directed by the HIV-1 LTR in transient expression assays both in the presence and absence of tat. Although the rate of HIV-1 transcription initiation was not affected by tat, transcriptional elongation beyond position +59 was seen only in the presence of tat. Thus, tat trans-activates HIV-1 transcription by relieving a specific block to transcriptional elongation within the TAR sequence.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
1. Chen, I. S. Y. Cell 47, 1-2 (1986). 2. Rosen, C. A., Sodroski, J. G. & Haseltine, W. A. Cell 41, 813-823 (1985). 3. Peterlin, B. M., Luciw, P. A., Barr, P. J. & Walker, M. D. Proc. natn. Acad. Sci. U.S.A. 83, 9734-9738 (1986). 4. Muesing, M. A., Smith, D. H. & Capon, D. J. Cell 48, 691-701 (1987). 5. Cullen, B. Cell 46, 973-982 (1986). 6. Wright, C. M., Felber, B. K., Paskalis, H. & Pavlakis, G. N. Science 234, 988-992 (1986). 7. Rosen, C. A. et al. Nature 319, 555-559 (1986). 8. Feinberg, M. B., Jarrett, R. F., Aldovini, A., Gallo, R. C. & Wong-Staal, F. Cell 46, 807-817 (1986). 9. Sodroski, J. G. et al. Science 229, 171-173 (1985). 10. Arya, S., Guo, C., Josephs, S. & Wong-Staal, F. Science 229, 69-73 (1985). 11. Sodroski, J. G., Patarca, R., Rosen, C. A., Wong-Staal, F. & Haseltine, W. A. Science 229, 74-77 (1985). 12. Dayton, A., Sodroski, J. G., Rosen, C. A., Goh, W. C. & Haseltine, W. A. Cell 44, 941-947 (1986). 13. Gluzman, Y. Cell 23, 175-182 (1981). 14. Mansour, S. L., Grodzicker, T. & Tjian, R. Molec. cell. Biol. 6, 2684-2694 (1986). 15. Barik, S., Ghosh, B., Whalen, W., Lazinski, D. & Das, A. Cell 50, 885-899 (1987). 16. Grayhack, E. J., Yang, Y., lau, L. F. & Roberts, J. W. Cell 42, 259-269 (1985). 17. Yanofsky, C. Nature 289, 751-758 (1981). 18. Von Hippel, P. H., Bear, D. H., Morgan, W. D. & McSwiggen, J. A. A. Rev. Biochem. 53, 389-446 (1984). 19. Platt, T. A. Rev. Biochem. 55, 339-372 (1986). 20. Dedrick, R. L., Kane, C. M. & Chamberlin, M. J. /. bioL Chem. 262, 9098-9108 (1987). 21. Reines, D., Wells, D., Chamberlin, M. J. & Kane, C. M. /. molec. Biol. 196, 299-312 (1987). 22. CnJi, G., Guise, J. W., McDevitt, M. A., Tucker, P. W. & Nevins, J. R. Genes Dev. 1, 471-481 (1987). 73. Bentley, D. L. & Groudine, M. Nature 321, 702-706 (1986). 24. Bender, T. P., Thompson, C. B. & Kuehl, W. M. Science 237, 1473-1476 (1987). 25. Rio, D. C. & Tjian, R. Cell 32, 1227-1240 (1983). 26. Lusky, M. & Botchan, M. Nature 293, 79-81 (1981). 27. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J. & Rutter, W. J. Biochemistry 18, 3294-3299 (1979). 28. Church, G. M. & Gilbert, W. Proc. natn. Acad. Sci. U.S.A. 81, 1991-1995 (1984). 29. Sanchez-Pescador, R. et al. Science 227, 484-492 (1985). 30. Queen, C. & Stafford, J. / molec. Biol. 4, 1042-1049 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kao, SY., Calman, A., Luciw, P. et al. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330, 489–493 (1987). https://doi.org/10.1038/330489a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/330489a0
This article is cited by
-
HIV co-opts a cellular antiviral mechanism, activation of stress kinase PKR by its RNA, to enable splicing of rev/tat mRNA
Cell & Bioscience (2023)
-
Molecular mechanisms by which the HIV-1 latent reservoir is established and therapeutic strategies for its elimination
Archives of Virology (2023)
-
Differences in Transcriptional Dynamics Between T-cells and Macrophages as Determined by a Three-State Mathematical Model
Scientific Reports (2020)
-
‘Mini’ U6 Pol III promoter exhibits nucleosome redundancy and supports multiplexed coupling of CRISPR/Cas9 effects
Gene Therapy (2020)
-
Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat
Epigenetics & Chromatin (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
